Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin M Miner

Showing results (21-30 of 49) with videos related to

Pageof 5
Sort By:
Postgraduate Medicine|July 3, 2013
12-month observation of testosterone replacement effectiveness in a general population of menMartin M Miner, Rajib K Bhattacharya, Gary Blick, et al.
Postgraduate Medicine|May 14, 2011
Baseline data from the TRiUS registry: symptoms and comorbidities of testosterone deficiencyMartin M Miner, Mohit Khera, Rajib K Bhattacharya, et al.
Clinical Interventions in Aging|September 8, 2012
Testosterone replacement therapy among elderly males: the Testim Registry in the US (TRiUS)Rajib K Bhattacharya, Mohit Khera, Gary Blick, et al.
The Journal of Urology|July 27, 2011
Changes in prostate specific antigen in hypogonadal men after 12 months of testosterone replacement therapy: support for the prostate saturation theoryMohit Khera, Rajib K Bhattacharya, Gary Blick, et al.
The Aging Male : the Official Journal of the International Society for the Study of the Aging Male|November 19, 2011
The effect of testosterone supplementation on depression symptoms in hypogonadal men from the Testim Registry in the US (TRiUS)Mohit Khera, Rajib K Bhattacharya, Gary Blick, et al.
Pain Medicine (Malden, Mass.)|April 28, 2012
Testosterone replacement therapy outcomes among opioid users: the Testim Registry in the United States (TRiUS)Gary Blick, Mohit Khera, Rajib K Bhattacharya, et al.
The Journal of Sexual Medicine|August 13, 2011
Improved sexual function with testosterone replacement therapy in hypogonadal men: real-world data from the Testim Registry in the United States (TRiUS)Mohit Khera, Rajib K Bhattacharya, Gary Blick, et al.
BMC Endocrine Disorders|November 3, 2011
Effect of 12 months of testosterone replacement therapy on metabolic syndrome components in hypogonadal men: data from the Testim Registry in the US (TRiUS)Rajib K Bhattacharya, Mohit Khera, Gary Blick, et al.
Mayo Clinic Proceedings|February 1, 2015
Testosterone therapy and cardiovascular risk: advances and controversiesAbraham Morgentaler, Martin M Miner, Monica Caliber, et al.
The Medical Clinics of North America|February 7, 2018
The Intersection of Medicine and Urology: An Emerging Paradigm of Sexual Function, Cardiometabolic Risk, Bone Health, and Men's Health CentersMartin M Miner, Joel Heidelbaugh, Mark Paulos, et al.
Pageof 5

Showing results (21-30 of 49) with videos related to

Sort By:
Pageof 5
Postgraduate Medicine|July 3, 2013
12-month observation of testosterone replacement effectiveness in a general population of menMartin M Miner, Rajib K Bhattacharya, Gary Blick, et al.
Postgraduate Medicine|May 14, 2011
Baseline data from the TRiUS registry: symptoms and comorbidities of testosterone deficiencyMartin M Miner, Mohit Khera, Rajib K Bhattacharya, et al.
Clinical Interventions in Aging|September 8, 2012
Testosterone replacement therapy among elderly males: the Testim Registry in the US (TRiUS)Rajib K Bhattacharya, Mohit Khera, Gary Blick, et al.
The Journal of Urology|July 27, 2011
Changes in prostate specific antigen in hypogonadal men after 12 months of testosterone replacement therapy: support for the prostate saturation theoryMohit Khera, Rajib K Bhattacharya, Gary Blick, et al.
The Aging Male : the Official Journal of the International Society for the Study of the Aging Male|November 19, 2011
The effect of testosterone supplementation on depression symptoms in hypogonadal men from the Testim Registry in the US (TRiUS)Mohit Khera, Rajib K Bhattacharya, Gary Blick, et al.
Pain Medicine (Malden, Mass.)|April 28, 2012
Testosterone replacement therapy outcomes among opioid users: the Testim Registry in the United States (TRiUS)Gary Blick, Mohit Khera, Rajib K Bhattacharya, et al.
The Journal of Sexual Medicine|August 13, 2011
Improved sexual function with testosterone replacement therapy in hypogonadal men: real-world data from the Testim Registry in the United States (TRiUS)Mohit Khera, Rajib K Bhattacharya, Gary Blick, et al.
BMC Endocrine Disorders|November 3, 2011
Effect of 12 months of testosterone replacement therapy on metabolic syndrome components in hypogonadal men: data from the Testim Registry in the US (TRiUS)Rajib K Bhattacharya, Mohit Khera, Gary Blick, et al.
Mayo Clinic Proceedings|February 1, 2015
Testosterone therapy and cardiovascular risk: advances and controversiesAbraham Morgentaler, Martin M Miner, Monica Caliber, et al.
The Medical Clinics of North America|February 7, 2018
The Intersection of Medicine and Urology: An Emerging Paradigm of Sexual Function, Cardiometabolic Risk, Bone Health, and Men's Health CentersMartin M Miner, Joel Heidelbaugh, Mark Paulos, et al.
Pageof 5